Evaluation of the FDA warning against prescribing citalopram at doses exceeding 40 mg. (Q34342685)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Evaluation of the FDA warning against prescribing citalopram at doses exceeding 40 mg. |
scientific article |
Statements
1 reference
Evaluation of the FDA warning against prescribing citalopram at doses exceeding 40 mg. (English)
1 reference
Helen C Kales
1 reference
Frederic C Blow
1 reference
Kara Zivin
1 reference
Paul N Pfeiffer
1 reference
Amy S B Bohnert
1 reference
Dara Ganoczy
1 reference
Brahmajee K Nallamothu
1 reference
1 reference
Identifiers
1 reference